Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Research breakthrough offers new hope for liver cancer treatment

20.07.2005


Scientists at The University of Nottingham have announced an important biological breakthrough that could offer new hope in the fight against liver cancer.

Professor John Mayer and Dr Simon Dawson, in collaboration with colleagues at Japan’s Kyoto University, have discovered the function of a new liver oncoprotein — or cancer causing protein — which could be the first step to finding effective new treatments for the deadly illness.

The research, published today in the journal Cancer Cell, centres on the most common malignant liver cancers, hepatocellular carcinomas, which arise from the liver cells themselves. Primary liver cancer is relatively rare in the UK and other countries in the Western world, but is very common in Africa and Asia — it is strongly associated with hepatitis virus infection and with a natural toxin called aflatoxin which is present in mouldy peanuts, soybeans, groundnut, corn and rice. There is currently no cure for primary liver cancer and survival rates are low.



The latest work by the Nottingham team has shown that a natural process in the liver, which would normally lead to cells dying before they can become cancerous, is being disrupted by the oncoprotein gankyrin.

The research stems from an international collaboration that began five years ago — the Nottingham team joined forces with Professor Jun Fujita and colleagues at Kyoto University after learning that both had simultaneously discovered the same new gene, which they intuitively believed played a significant role in liver cancer. Together they set about identifying the function of the new gene.

The team has found that in most cases of liver-derived cancers the gene is overexpressed. It is this gene that produces gankyrin, which effectively stimulates the destruction of another vital protein in the liver called p53, which is essential in protecting the liver from cancer.

The process is part of the ubiquitin proteasome system (UPS) — the body’s natural method of breaking down proteins discovered by Aaron Ciechanover and Avram Hershko of the Israel Institute of Technology and Irwin Rose of the University of California, for which they were awarded the 2004 Nobel Prize for Chemistry.

The protein p53, sometimes called the ‘guardian of the genome’, is charged with the task of regulating cell division in the liver — it decides which cells should continue dividing and replicating their DNA and which should die. If a cell is infected with a virus, p53 sends out a signal to the cell, triggering a process called apoptosis — in which the cell effectively commits suicide.

In primary liver cancer, the team of scientists have discovered that this process is disrupted. Instead, the gankyrin binds to an enzyme called mdm2, which gives the p53 protein a molecular label which marks it for death. It is sent to the cell’s waste disposer, the proteasome, where it is broken down and destroyed. Damaged cells can then continue dividing and growing into a tumour.

The next step is to learn more about how and why this takes place, in the hope that eventually new therapies could be developed that will disrupt this biological process and halt the growth of tumours.

Professor John Mayer | alfa
Further information:
http://www.nottingham.ac.uk

More articles from Life Sciences:

nachricht The balancing act: An enzyme that links endocytosis to membrane recycling
07.12.2016 | National Centre for Biological Sciences

nachricht Transforming plant cells from generalists to specialists
07.12.2016 | Duke University

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

NTU scientists build new ultrasound device using 3-D printing technology

07.12.2016 | Health and Medicine

The balancing act: An enzyme that links endocytosis to membrane recycling

07.12.2016 | Life Sciences

How to turn white fat brown

07.12.2016 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>